Delta-beta thalassemia digital illustration

Delta-beta thalassemia Save


ICD-10 code: D56.2

Disease category: D56: Thalassemia

Understanding Delta-Beta Thalassemia: Causes and Symptoms

Delta-beta thalassemia is a rare genetic blood disorder characterized by abnormalities in the production of the delta and beta chains of hemoglobin. Hemoglobin is a protein responsible for carrying oxygen throughout the body. This condition can have significant effects on a person's health, but it is essential to note that it does not have a specific treatment.

Causes:

  1. Genetic Mutation: Delta-beta thalassemia is caused by mutations in the HBB gene, which provides instructions for making the beta globin protein. These mutations disrupt the normal production of hemoglobin.
  2. Inheritance: Delta-beta thalassemia is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the mutated gene, one from each parent, to develop the condition.

Symptoms:

The severity of symptoms can vary widely among individuals with delta-beta thalassemia. Some individuals may experience mild symptoms, while others may have more severe complications. Common symptoms include:

  • Anemia: Delta-beta thalassemia can lead to chronic anemia, causing fatigue, weakness, and pale skin.
  • Delayed Growth: Children with delta-beta thalassemia may experience delayed growth and development due to the lack of normal hemoglobin production.
  • Bone Deformities: In severe cases, bone marrow expansion can lead to bone deformities, such as facial changes and abnormal bone structure.
  • Splenomegaly: Enlargement of the spleen is a common complication, which can cause abdominal discomfort and increase the risk of infections.

Diagnosis:

Delta-beta thalassemia is typically diagnosed through blood tests that evaluate the levels of hemoglobin and red blood cells. Additional tests, such as genetic testing, can confirm the presence of specific mutations in the HBB gene.

Management and Support:

Although there is no cure for delta-beta thalassemia, individuals can manage the symptoms and complications through regular medical care. Treatment options may include blood transfusions to alleviate anemia and medications to manage associated complications.

In conclusion, delta-beta thalassemia is a genetic blood disorder caused by mutations in the HBB gene. It can lead to chronic anemia, delayed growth, bone deformities, and enlargement of the spleen. Early diagnosis and regular medical care are essential to manage the condition effectively and improve the quality of life for individuals with delta-beta thalassemia.

Treatment of Delta-beta thalassemia:

Treatment Options for Delta-Beta Thalassemia

Delta-beta thalassemia is a rare genetic blood disorder that affects the production of hemoglobin, the protein responsible for carrying oxygen in the body. Individuals with this condition often require treatment to manage their symptoms and improve their quality of life. Here are some treatment options for delta-beta thalassemia:

To see full information about treatment please Sign up or Log in